Curileum
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Northwick Park & St Mark's Hospital Camp...Phone Number
+44 2081232801Website
www.curileum.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Curileum
Curileum is focused on developing novel therapies aimed at restoring the health of gastrointestinal (GI) tissues to prevent bowel cancer and treat inflammatory bowel disease (IBD). Their key products include ULI262, a first-in-class small molecule drug targeting abnormal cell production related to bowel cancer, and the ATZ Platform, which offers potential curative treatments for perianal fistulas in Crohn's patients. The company collaborates with leading industrial and academic institutions to advance early-stage research and is based near St Marks Hospital in London, a center dedicated to GI diseases. With over 40 years of drug discovery experience, Curileum has raised significant funding to support the development of its innovative GI therapies.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Curileum your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Curileum has new funding data
Curileum, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Curileum had a recent Job posting/layoffs
Check out if Curileum is spiking on competitors!
Check if Curileum has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Curileum launches new products
Congratulate Masked Content for being promoted to Masked Content at Curileum
Earning: See what the market has to say on Curileum recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Curileum
Find 2 more new buyers
Compare Similar Companies to Curileum
Compare insights from companies similar to Curileum, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Curileum
<$5M
1-10
Private
-
2013
N/A
Company Profile Activity
Activity Insights
Curileum is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Curileum is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Curileum.
Curileum Tech Stack
A closer look at the technologies used by Curileum
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Curileum
Sign Up For FreeTo access detailed company insights
Curileum is focused on developing novel therapies aimed at restoring the health of gastrointestinal (GI) tissues to prevent bowel cancer and treat inflammatory bowel disease (IBD). Their key products include ULI262, a first-in-class small molecule drug targeting abnormal cell production related to bowel cancer, and the ATZ Platform, which offers po... Read More
